XML 31 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 460,359 $ 508,104
Accounts receivable, net of allowances of $21,851 and $28,980 as of March 31, 2024 and December 31, 2023, respectively 760,092 744,129
Inventories 720,628 713,485
Prepaid expenses and other current assets 157,441 136,686
Total current assets 2,098,520 2,102,404
Property, plant and equipment, net 883,851 886,010
Goodwill 3,542,725 3,542,770
Other intangible assets, net of accumulated amortization of $2,561,367 and $2,522,760 as of March 31, 2024 and December 31, 2023, respectively 845,555 883,671
Deferred income tax assets 127,491 131,527
Other assets 117,808 134,605
Total assets 7,615,950 7,680,987
Current liabilities:    
Current portion of long-term debt, finance lease and other financing obligations 2,340 2,276
Accounts payable 469,342 482,301
Income taxes payable 33,762 32,139
Accrued expenses and other current liabilities 288,525 307,002
Total current liabilities 793,969 823,718
Deferred income tax liabilities 361,172 359,073
Pension and other post-retirement benefit obligations 38,053 38,178
Finance lease obligations, less current portion 22,587 22,949
Long-term debt, net 3,375,511 3,373,988
Other long-term liabilities 49,824 66,805
Total liabilities 4,641,116 4,684,711
Commitments and contingencies (Note 11)
Shareholders’ equity:    
Ordinary shares, €0.01 nominal value per share, 177,069 shares authorized, and 175,839 and 175,832 shares issued as of March 31, 2024 and December 31, 2023, respectively 2,249 2,249
Treasury shares, at cost, 25,365 and 25,090 shares as of March 31, 2024 and December 31, 2023, respectively (1,223,212) (1,213,160)
Additional paid-in capital 1,837,647 1,901,621
Retained earnings 2,353,440 2,295,604
Accumulated other comprehensive income 4,710 9,962
Total shareholders' equity 2,974,834 2,996,276
Total liabilities and shareholders' equity $ 7,615,950 $ 7,680,987